Martin Löwer

9.8k total citations · 3 hit papers
44 papers, 4.1k citations indexed

About

Martin Löwer is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Martin Löwer has authored 44 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 24 papers in Immunology and 10 papers in Oncology. Recurrent topics in Martin Löwer's work include Immunotherapy and Immune Responses (17 papers), vaccines and immunoinformatics approaches (15 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Martin Löwer is often cited by papers focused on Immunotherapy and Immune Responses (17 papers), vaccines and immunoinformatics approaches (15 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Martin Löwer collaborates with scholars based in Germany, Switzerland and United States. Martin Löwer's co-authors include Uğur Şahin, Özlem Türeci, Barbara Schrörs, Sebastian Boegel, Mustafa Diken, John C. Castle, Sebastian Kreiter, Jan Diekmann, Niels van de Roemer and Christoph Huber and has published in prestigious journals such as Nature, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Martin Löwer

44 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mutant MHC class II epitopes drive therapeutic immune responses to cancer

2015 915 citations Sebastian Kreiter, Mathias Vormehr et al. Nature profile →
Exploiting the Mutanome for Tumor Vaccination

2012 617 citations John C. Castle, Sebastian Kreiter et al. Cancer Research profile →
Identification of neoantigens for individualized therapeutic cancer vaccines

2022 330 citations Franziska Lang, Barbara Schrörs et al. Nature Reviews Drug Discovery profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Martin Löwer Germany	24	2.5k	1.9k	1.8k	374	361	44	4.1k
Arthur E. Frankel United States	40	2.5k 1.0×	2.6k 1.4×	1.4k 0.8×	495 1.3×	509 1.4×	144	5.2k
Phillip Wong United States	31	3.2k 1.3×	1.5k 0.8×	1.3k 0.7×	555 1.5×	149 0.4×	91	5.4k
Franca Ronchese New Zealand	43	4.4k 1.8×	1.3k 0.7×	1.2k 0.7×	215 0.6×	291 0.8×	118	5.9k
Pablo Sarobe Spain	39	2.6k 1.1×	1.5k 0.8×	2.0k 1.1×	525 1.4×	382 1.1×	125	5.5k
Masaki Terabe United States	42	4.7k 1.9×	1.6k 0.9×	2.4k 1.3×	459 1.2×	198 0.5×	101	6.5k
Sandra Hervás‐Stubbs Spain	39	3.7k 1.5×	2.1k 1.1×	2.8k 1.6×	565 1.5×	287 0.8×	111	6.7k
Sebastian Kreiter Germany	29	2.9k 1.2×	2.6k 1.4×	1.9k 1.1×	259 0.7×	340 0.9×	64	4.6k
David Escors Spain	43	2.7k 1.1×	1.6k 0.9×	2.4k 1.4×	292 0.8×	211 0.6×	128	5.5k
Tibor Keler United States	46	4.2k 1.7×	1.9k 1.0×	2.4k 1.3×	215 0.6×	974 2.7×	153	6.0k
Jean‐Pierre Abastado France	41	3.1k 1.2×	1.3k 0.7×	1.3k 0.7×	303 0.8×	340 0.9×	95	4.8k

Countries citing papers authored by Martin Löwer

Since Specialization

Citations

This map shows the geographic impact of Martin Löwer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Löwer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Löwer more than expected).

Fields of papers citing papers by Martin Löwer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Löwer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Löwer. The network helps show where Martin Löwer may publish in the future.

Co-authorship network of co-authors of Martin Löwer

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Löwer. A scholar is included among the top collaborators of Martin Löwer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Löwer. Martin Löwer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lang, Franziska, Patrick Sorn, M Suchan, et al.. (2024). Prediction of tumor-specific splicing from somatic mutations as a source of neoantigen candidates. Bioinformatics Advances. 4(1). vbae080–vbae080. 2 indexed citations

Weber, David, Martin Löwer, Valesca Bukur, et al.. (2024). Temporal evolution and inter-patient heterogeneity in primary and recurrent head and neck squamous cell carcinoma. SHILAP Revista de lepidopterología. 2(1). 62–62. 1 indexed citations

Lang, Franziska, Barbara Schrörs, Martin Löwer, Özlem Türeci, & Uğur Şahin. (2023). Author Correction: Identification of neoantigens for individualized therapeutic cancer vaccines. Nature Reviews Drug Discovery. 23(2). 156–156. 4 indexed citations

Bukur, Thomas, Pablo Riesgo-Ferreiro, Patrick Sorn, et al.. (2023). CoVigator—A Knowledge Base for Navigating SARS-CoV-2 Genomic Variants. Viruses. 15(6). 1391–1391. 2 indexed citations

Weber, David, Jonas Ibn-Salem, Patrick Sorn, et al.. (2022). Accurate detection of tumor-specific gene fusions reveals strongly immunogenic personal neo-antigens. Nature Biotechnology. 40(8). 1276–1284. 34 indexed citations

Lang, Franziska, Barbara Schrörs, Martin Löwer, Özlem Türeci, & Uğur Şahin. (2022). Identification of neoantigens for individualized therapeutic cancer vaccines. Nature Reviews Drug Discovery. 21(4). 261–282. 330 indexed citations breakdown →

Costa, Barbara, Michael Fletcher, Ekaterina Ivanova, et al.. (2021). A Set of Cell Lines Derived from a Genetic Murine Glioblastoma Model Recapitulates Molecular and Morphological Characteristics of Human Tumors. Cancers. 13(2). 230–230. 15 indexed citations

Weber, David, Martin Löwer, Valesca Bukur, et al.. (2021). Comprehensive Genomic and Transcriptomic Analysis of Three Synchronous Primary Tumours and a Recurrence from a Head and Neck Cancer Patient. International Journal of Molecular Sciences. 22(14). 7583–7583. 3 indexed citations

Lang, Franziska, Pablo Riesgo-Ferreiro, Martin Löwer, Uğur Şahin, & Barbara Schrörs. (2021). NeoFox: annotating neoantigen candidates with neoantigen features. Bioinformatics. 37(22). 4246–4247. 10 indexed citations

10.

Becker, Julia Powers, Jos de Graaf, Martin Löwer, et al.. (2020). Integrative analysis of structural variations using short-reads and linked-reads yields highly specific and sensitive predictions. PLoS Computational Biology. 16(11). e1008397–e1008397. 6 indexed citations

11.

Türeci, Özlem, Martin Löwer, Barbara Schrörs, et al.. (2018). Challenges towards the realization of individualized cancer vaccines. Nature Biomedical Engineering. 2(8). 566–569. 38 indexed citations

12.

Miller, Matthias, Uğur Şahin, Evelyna Derhovanessian, et al.. (2017). IVAC MUTANOME: A first-in-human phase I clinical trial targeting individual mutant neoantigens for the treatment of melanoma. Annals of Oncology. 28. xi1–xi2. 13 indexed citations

13.

Canli, Özge, Adele M. Nicolas, J. R. P. Gupta, et al.. (2017). Myeloid Cell-Derived Reactive Oxygen Species Induce Epithelial Mutagenesis. Cancer Cell. 32(6). 869–883.e5. 273 indexed citations

14.

Frenzel, Katrin, Ludwig Heesen, Stefanie Bolte, et al.. (2017). Mutanome engineered RNA immuno-therapy (MERIT) for patients with triple negative breast cancer. Annals of Oncology. 28. xi29–xi29. 2 indexed citations

15.

Boegel, Sebastian, Jelle Scholtalbers, Martin Löwer, Uğur Şahin, & John C. Castle. (2015). In Silico HLA Typing Using Standard RNA-Seq Sequence Reads. Methods in molecular biology. 1310. 247–258. 11 indexed citations

16.

Kreiter, Sebastian, Mathias Vormehr, Niels van de Roemer, et al.. (2015). Mutant MHC class II epitopes drive therapeutic immune responses to cancer. Nature. 520(7549). 692–696. 915 indexed citations breakdown →

17.

Boegel, Sebastian, Martin Löwer, Thomas Bukur, Uğur Şahin, & John C. Castle. (2014). A catalog of HLA type, HLA expression, and neo-epitope candidates in human cancer cell lines. OncoImmunology. 3(8). e954893–e954893. 79 indexed citations

18.

Castle, John C., Sebastian Kreiter, Jan Diekmann, et al.. (2012). Exploiting the Mutanome for Tumor Vaccination. Cancer Research. 72(5). 1081–1091. 617 indexed citations breakdown →

19.

Hoy, Benjamin, Martin Löwer, Gert Carra, et al.. (2010). Helicobacter pylori HtrA is a new secreted virulence factor that cleaves E‐cadherin to disrupt intercellular adhesion. EMBO Reports. 11(10). 798–804. 246 indexed citations

20.

Löwer, Martin, Dirk Metzler, Andreas Reuter, et al.. (2008). Prediction of Extracellular Proteases of the Human Pathogen Helicobacter pylori Reveals Proteolytic Activity of the Hp1018/19 Protein HtrA. PLoS ONE. 3(10). e3510–e3510. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact